Transce3nd’s NOV NOV Stock Holding History

Transce3nd’s Portfolio NOV Stock Details NOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-87	Closed	-$1.08K	–	796
2025 Q2	$1.08K	Hold	87	–	–	﹤0.01%	970
2025 Q1	$1.32K	Sell	87 -6	-6%	-$90	﹤0.01%	919
2024 Q4	$1.36K	Buy	+93	New	+$1.45K	﹤0.01%	1160

Other funds holding NOV

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FPA

First Pacific Advisors El Segundo, California $8.09B AUM 21.95% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Transce3nd's NOV Position: Q3 2025 in Review

Transce3nd sold out of NOV (NOV) in Q3 2025, closing a stake of 87 shares — an estimated $1.08K sold.

Transce3nd first reported a position in NOV in Q4 2024 and held it in 3 quarters. The position peaked at $1.36K in Q4 2024. 428 funds tracked by Wall St. Rank hold NOV as of Q3 2025.

Transce3nd reported no remaining NOV position as of Q3 2025 after selling out during the quarter.
Transce3nd sold 87 NOV shares in Q3 2025, an estimated $1.08K.
Transce3nd first reported a position in NOV in Q4 2024 and held it in 3 quarters.
Transce3nd's NOV position peaked at $1.36K in Q4 2024.
428 funds tracked by Wall St. Rank held NOV as of Q3 2025.

Based on Transce3nd's 13F filing for Q3 2025, filed 12 Nov 2025.